Federal record
FDA Warning Letter issued April 23, 2025 · As of September 2026, Vial did not find a close-out letter in FDA records. Read the FDA letter →
We're providing this information based on regulatory filings Vial reviewed as of 2026-09-23. Regulatory status can change, and actions may be resolved or closed out. Confirm current status with the issuing agency: FDA.gov →
OSRX, Inc.
Missoula, MT
Is this your company? Claim this profile.
OSRX is a pharmacy. The FDA issued a warning letter involving OSRX on April 23, 2025, with no close-out letter found resolving it. Pricing was not publicly listed, so total cost should be confirmed before signing up.
What they offerPharmacy
Why this score?
The Vial Score measures how much of this provider's public record Vial could confirm, and how clearly the provider discloses it. It does not measure quality of care.
| 85-100 | High Confidence |
| 70-84 | Well Documented |
| 50-69 | Limited Confidence |
| 0-49 | Flagged |
OSRX, Inc. scores 38, in the Flagged band. The score moves when the public record changes. For OSRX, Inc., the item most likely to move it: Pricing.
Payment never changes a score.
3 of 5 checks complete. The remaining checks have not been run yet. Missing checks reduce how complete the profile is. They are not a finding by themselves.
Score history
- 38June 2026Record updated
- 61June 2026Record updated
- 38June 2026Vial scoring update
- 46May 2026Record updated
- 38May 2026
What we found on OSRX, Inc.
We reviewed FDA enforcement records, OIG exclusions, DEA registration, HIPAA breach records, and NPI registration.
The FDA issued a warning letter involving OSRX, Inc. on April 23, 2025. We have not found a close-out letter resolving it as of our last check (September 23, 2026); read the details below before going further. The company appears in the federal NPI registry. Our findings reflect public records reviewed as of September 2026.
Why this score: 3 of 5 checks complete. Each links to the public source it was verified against.
A check we haven’t completed yet is not a mark against this provider. It just means we’re still sourcing that record. The score reflects what we’ve confirmed so far, and updates as more checks come in.
Vial describes the record, not the provider. This is not a medical recommendation or endorsement. Last reviewed September 1, 2026.
Our take
Vial EditorialBased on the records and public materials we reviewed.
The FDA issued a warning letter to OSRX, Inc. on April 23, 2025. We have not found a close-out letter resolving it. Before using this pharmacy, ask what changed after the letter and confirm current status with FDA.
Questions we’d want answered
Worth asking before you choose
Ask these before you sign up.
- 1What changed after the FDA warning letter?
- 2Has FDA issued a close-out letter?
- 3Are you operating as a 503A pharmacy or a 503B outsourcing facility?
- 4Which states are you licensed to ship to?
- 5Can you provide current state pharmacy license details?
See all 5 questionsShow fewer
Screenshot these or show your doctor: they’re the same questions Vial would ask.
Compare record details
Arcadia Pharmacy has no federal action found; OSRX, Inc. has an FDA warning letter with no close-out letter found.
OSRX, Inc. scores 38, Arcadia Pharmacy scores 82.
| OSRX, Inc. | Arcadia Pharmacy | |
|---|---|---|
| Federal actions | Confirmed | None found |
| Vial Score | 38/100 | 82/100 |
| LegitScript certified | No | No |
| PCAB accredited | No | No |
What Vial measures, and what we don’t
We evaluate public records: federal enforcement history, registrations, certifications, and how transparent a provider is about its clinicians, pharmacies, and pricing. We don’t score bedside manner, clinical outcomes, or customer satisfaction, and we don’t collect user reviews.
Other pharmacy providers in Vial
Other Pharmacy in Vial’s directory. Open a profile, or compare side by side.
Not sure where to start?Answer a few questions and we’ll narrow the directory to providers that fit.
Find your providerThis page evaluates compliance signals, not clinical outcomes. Consult a licensed physician before starting any therapy, medication, or treatment. Vial does not provide medical advice.